- Gastroenteritis testing, which involves the detection of viral, bacterial, or parasitic pathogens responsible for gastrointestinal infections, is becoming an essential part of public health management and clinical diagnostics due to its ability to enable early and accurate treatment decisions
- The growing demand for gastroenteritis testing is primarily driven by the increasing prevalence of gastrointestinal diseases, rising global food and water contamination incidents, and heightened awareness regarding timely and accurate diagnostics
- North America dominated the gastroenteritis testing market with the largest revenue share of 40% in 2024, supported by well-established healthcare infrastructure, advanced diagnostic technologies, and widespread access to clinical laboratories, with the U.S. leading in test volumes owing to routine screening protocols and investments in molecular diagnostics
- Asia-Pacific is expected to be the fastest growing region in the gastroenteritis testing market during the forecast period due to expanding healthcare access, increasing government initiatives for infectious disease control, and rising healthcare expenditure
- The molecular diagnostics segment dominated the gastroenteritis testing market with a market share of 42% in 2024, attributed to its superior accuracy, speed, and ability to simultaneously detect multiple pathogens, making it the preferred choice in hospital and reference lab settings
